Indoco Remedies Ltd

Indoco Remedies Ltd

Indoco Remedies Ltd has announced the Notice of the 79th Annual General Meeting (AGM) and Annual Report for the financial year 2025-2026. The AGM will be held on September 17, 2026, via video conference and other audio-visual means. The company has also provided details on the final dividend record date, book closure, and e-voting schedule.

Indoco Remedies Ltd

Indoco Remedies Ltd has announced the cut-off date for e-voting, book closure, and record date for the final dividend of Rs. 0.20 per equity share for the financial year ended 31st March, 2026. The record date is 10th September, 2026, and the dividend will be paid within 30 days if approved at the 79th Annual General Meeting on 17th September, 2026.

Indoco Remedies Ltd

Indoco Remedies Ltd has published a newspaper advertisement for its 79th Annual General Meeting to be held on 17th September, 2026 through Video Conferencing (VC)/ Other Audio-Visual Means (OAVM). The meeting will be held in compliance with the applicable provisions of the Companies Act, 2013 and rules framed there under, SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and other circulars issued in this regard.

Indoco Remedies Ltd

Indoco Remedies Ltd announced its unaudited standalone and consolidated financial results for the quarter ended 30th June, 2026, with a 5.8% year-on-year growth in standalone operational revenue to INR4,081 million and an 8.2% year-on-year increase in consolidated revenue to INR4,662 million. The company maintained its growth trajectory and focus on strategic execution, with a steady performance highlighting its operating momentum backed by strong execution across its core domestic formulations franchise, regulated international markets, and vertically integrated API platform.

Indoco Remedies Ltd

Indoco Remedies Ltd has published its unaudited standalone and consolidated financial results for the quarter ended 30-06-2026, showing a net profit of Rs. 8,232 lakhs and a total income of Rs. 40,897 lakhs.

Indoco Remedies Ltd

Indoco Remedies Ltd has made available the audio recording of its earnings conference call for the quarter ended 30-06-2026, which was held on 28th July, 2026. The recording is available on the company's website.

Indoco Remedies Ltd

Indoco Remedies Ltd has announced the re-appointment of Ms. Aditi Panandikar as Managing Director for a period of 5 years, subject to shareholder approval, and the appointment of Mr. Sudhir Kadam as Senior Management Personnel.

Indoco Remedies Ltd

Indoco Remedies Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended 30th June, 2026, with a net profit of Rs. 8,232 lakhs and a revenue from operations of Rs. 40,897 lakhs. The company has also completed the slump sale of its Ophthalmic Business Division to Sunways (India) Private Limited, resulting in a gain of Rs. 9,734 lakhs.

Indoco Remedies Ltd

Indoco Remedies Ltd has announced its unaudited standalone financial results for the quarter ended 30th June, 2026. The company has reported a profit of Rs. 8,232 lakhs for the quarter, with a total income from operations of Rs. 40,897 lakhs. The statutory auditors have expressed an unmodified audit opinion on these unaudited financial results. The company has completed the slump sale of its Ophthalmic Business Division to Sunways (India) Private Limited, resulting in a gain of Rs. 9,734 lakhs, which has been recognized as an Exceptional Item.